Cowen Inc. announced that Steven Mah, Ph.D., has joined the Company's equity research team to further expand the firm's coverage of the life science & diagnostic tools sector. He will be based in New York, and will report to Robert Fagin, Cowen's Head of Research. Prior to joining Cowen, Dr. Mah was a senior analyst for life science & diagnostic tools at Piper Sandler, and earlier in his career was a Principal in Piper Sandler's health care investment banking group, where he focused on mergers and acquisitions as well as equity and equity-linked transactions.
1st Jan change | Capi. | |
---|---|---|
+6.75% | 165B | |
+19.34% | 157B | |
+5.63% | 138B | |
+23.60% | 122B | |
-5.20% | 37.02B | |
+10.23% | 25.62B | |
-5.80% | 21.14B | |
+21.18% | 20.37B | |
+48.36% | 17.6B |